GlassScriptPhysician profile
Alpesh A Patel
NPI 1639192164
$916,639.91
in general payments reported to CMS, 2019-2025
31 companies · $155K in 2025
The $155K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $52K · 2021: $98K · 2022: $159K · 2023: $116K · 2024: $289K · 2025: $155K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $420K · Consulting Fee: $97K · Travel and Lodging: $35K · Food and Beverage: $8,482 · Entertainment: $248 · Gift: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $420,311.01 |
| Consulting Fee | $96,709.58 |
| Travel and Lodging | $34,555.71 |
| Food and Beverage | $8,481.86 |
| Entertainment | $248.23 |
| Gift | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $367,210.33 | 2019-2025 | Other - Miscellaneous, Identiti, Biologics |
| Nuvasive, INC. | $242,372.73 | 2019-2023 | Modulus |
| Globus Medical, INC. | $167,965.86 | 2024-2025 | Modulus, Modulus, Coalition |
| Ctl Medical Corporation | $46,249.54 | 2019-2024 | Spinal |
| Kuros Biosciences Ag | $30,734.41 | 2024-2025 | Magnetos |
| Kuros Biosciences USA, INC | $18,389.15 | 2021-2025 | Magnetos |
| Medical Device Business Services, INC. | $13,769.95 | 2021-2025 | Velys |
| Depuy Synthes Products, INC. | $9,427.65 | 2019 | |
| Orthofix Medical, INC. | $5,752.44 | 2023-2025 | 7d Surgical System, Miscellaneous, Mariner Deformity |
| Ethicon US, LLC | $4,750.00 | 2021-2022 | |
| Medtronic, INC. | $2,768.55 | 2021-2025 | Mazor X System, Medtronic Reusable Instruments |
| Zimmer Biomet Holdings, INC. | $1,800.00 | 2019-2020 | |
| United Orthopedics LLC | $1,200.00 | 2022 | |
| Lightbody Medical Technologies INC | $1,147.69 | 2024-2025 | |
| Stryker Corporation | $1,090.57 | 2019-2024 | N/A, Everest Spinal System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $383.99 | 2024-2025 | |
| Synthes Gmbh | $250.00 | 2022 | |
| Medtronic USA, INC. | $206.01 | 2019 | |
| Cerapedics INC. | $191.45 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $143.41 | 2023 | |
| Depuy Synthes Sales INC. | $135.88 | 2019-2025 | Velys, Teligen |
| Si-Bone, INC. | $127.85 | 2021 | |
| Carlsmed, INC. | $127.70 | 2023-2025 | Aprevo |
| Bioventus LLC | $108.36 | 2021 | |
| Ferring Pharmaceuticals INC. | $96.17 | 2021 | |
| Zimvie INC. | $77.61 | 2023 | |
| Argentum Medical | $58.44 | 2021 | |
| Abiomed | $42.99 | 2024 | Impella |
| Seaspine Orthopedics Corporation | $40.00 | 2019 | |
| Pfizer INC. | $21.18 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$193,182.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.